{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T00:12:59Z","timestamp":1794528779639,"version":"4.9.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Clinics of North America"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.suc.2018.12.008","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T01:22:13Z","timestamp":1551748933000},"page":"337-355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":148,"title":["Gallbladder Cancer"],"prefix":"10.1016","volume":"99","author":[{"given":"Laura","family":"Hickman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.suc.2018.12.008_bib1","series-title":"AJCC cancer staging handbook: from the AJCC cancer staging manual","year":"2010"},{"issue":"13","key":"10.1016\/j.suc.2018.12.008_bib2","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1245\/s10434-016-5470-2","article-title":"Changing odds of survival over time among patients undergoing surgical resection of gallbladder carcinoma","volume":"23","author":"Buettner","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.suc.2018.12.008_bib3","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s00268-011-1134-3","article-title":"Incidental gallbladder cancer by the AFC-GBC-2009 Study Group","volume":"35","author":"Fuks","year":"2011","journal-title":"World J Surg"},{"issue":"2","key":"10.1016\/j.suc.2018.12.008_bib4","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.surg.2017.02.009","article-title":"Predictors of incidental gallbladder cancer in patients undergoing cholecystectomy for benign gallbladder disease: Results from a population-based gallstone surgery registry","volume":"162","author":"Muszynska","year":"2017","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.suc.2018.12.008_bib5","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3748\/wjg.v21.i4.1315","article-title":"Clinical characteristics of incidental or unsuspected gallbladder cancers diagnosed during or after cholecystectomy: a systematic review and meta-analysis","volume":"21","author":"Choi","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.suc.2018.12.008_bib6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1177\/000313481708300721","article-title":"Pathologic and prognostic implications of incidental versus nonincidental gallbladder cancer: a 10-Institution Study from the United States Extrahepatic Biliary Malignancy Consortium","volume":"83","author":"Ethun","year":"2017","journal-title":"Am Surg"},{"issue":"8","key":"10.1016\/j.suc.2018.12.008_bib7","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/hpb.12444","article-title":"Gallbladder cancer: expert consensus statement","volume":"17","author":"Aloia","year":"2015","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.suc.2018.12.008_bib8","doi-asserted-by":"crossref","first-page":"1532835","DOI":"10.1155\/2017\/1532835","article-title":"Gallbladder carcinoma in the United States: a population based clinical outcomes study involving 22,343 patients from the surveillance, epidemiology, and end result database (1973-2013)","volume":"2017","author":"Lau","year":"2017","journal-title":"HPB Surg"},{"key":"10.1016\/j.suc.2018.12.008_bib9","series-title":"NCCN Clinical Practice Guidelines in Oncology: Hepatobiliary Cancers. Version 5.2018","author":"Benson","year":"2018"},{"issue":"15","key":"10.1016\/j.suc.2018.12.008_bib10","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/jnci\/89.15.1132","article-title":"Epidemiologic aspects of gallbladder cancer: a case-control study of the SEARCH Program of the International Agency for Research on Cancer","volume":"89","author":"Zatonski","year":"1997","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"22","key":"10.1016\/j.suc.2018.12.008_bib11","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.3748\/wjg.v23.i22.3978","article-title":"Gallbladder cancer epidemiology, pathogenesis and molecular genetics: recent update","volume":"23","author":"Sharma","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"4","key":"10.1016\/j.suc.2018.12.008_bib12","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/cam4.1044","article-title":"Trend analysis and survival of primary gallbladder cancer in the United States: a 1973-2009 population-based study","volume":"6","author":"Rahman","year":"2017","journal-title":"Cancer Med"},{"issue":"8","key":"10.1016\/j.suc.2018.12.008_bib13","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/cncr.11699","article-title":"Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies","volume":"98","author":"Jarnagin","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.suc.2018.12.008_bib14","series-title":"AJCC cancer staging manual","year":"2017"},{"issue":"6","key":"10.1016\/j.suc.2018.12.008_bib15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.ejso.2010.05.002","article-title":"Cholelithiasis in gallbladder cancer: coincidence, cofactor, or cause!","volume":"36","author":"Shrikhande","year":"2010","journal-title":"Eur J Surg Oncol"},{"issue":"Pt A","key":"10.1016\/j.suc.2018.12.008_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijsu.2016.07.061","article-title":"The risk of malignancy in ultrasound detected gallbladder polyps: a systematic review","volume":"33","author":"Elmasry","year":"2016","journal-title":"Int J Surg"},{"issue":"4","key":"10.1016\/j.suc.2018.12.008_bib17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1158\/1055-9965.EPI-16-0796","article-title":"Body size indicators and risk of gallbladder cancer: pooled analysis of individual-level data from 19 prospective cohort studies","volume":"26","author":"Campbell","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"12","key":"10.1016\/j.suc.2018.12.008_bib18","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1007\/s10620-016-4310-3","article-title":"Familial risk of biliary tract cancers: a population-based study in Utah","volume":"61","author":"Samadder","year":"2016","journal-title":"Dig Dis Sci"},{"issue":"4","key":"10.1016\/j.suc.2018.12.008_bib19","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1136\/gut.52.4.592","article-title":"Familial liver and gall bladder cancer: a nationwide epidemiological study from Sweden","volume":"52","author":"Hemminki","year":"2003","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.suc.2018.12.008_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/jso.23239","article-title":"Predictors of incidental gallbladder cancer in patients undergoing cholecystectomy for benign gallbladder disease","volume":"107","author":"Koshenkov","year":"2013","journal-title":"J\u00a0Surg Oncol"},{"issue":"6","key":"10.1016\/j.suc.2018.12.008_bib21","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.rcl.2017.06.005","article-title":"Imaging and screening of cancer of the gallbladder and bile ducts","volume":"55","author":"Sandrasegaran","year":"2017","journal-title":"Radiol Clin North Am"},{"issue":"9","key":"10.1016\/j.suc.2018.12.008_bib22","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/PAS.0b013e318262787c","article-title":"Intracholecystic papillary-tubular neoplasms (ICPN) of the gallbladder (neoplastic polyps, adenomas, and papillary neoplasms that are \u22651.0\u00a0cm): clinicopathologic and immunohistochemical analysis of 123 cases","volume":"36","author":"Adsay","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.suc.2018.12.008_bib23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1067\/msy.2001.113888","article-title":"Carcinoma in the porcelain gallbladder: a relationship revisited","volume":"129","author":"Stephen","year":"2001","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.suc.2018.12.008_bib24","first-page":"1064","article-title":"Porcelain Gallbladder: Is Observation a Safe Option in Select Populations?","volume":"226","author":"DesJardins","year":"2018","journal-title":"JACS"},{"issue":"1","key":"10.1016\/j.suc.2018.12.008_bib25","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12957-016-1039-6","article-title":"A\u00a0case of neuroendocrine carcinoma in the hepatic hilar lymph nodes concomitant with an adenocarcinoma of the gallbladder","volume":"14","author":"Okada","year":"2016","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10.1016\/j.suc.2018.12.008_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40792-016-0200-3","article-title":"Gallbladder small cell carcinoma: a case report and literature review","volume":"2","author":"Adachi","year":"2016","journal-title":"Surg Case Rep"},{"issue":"5","key":"10.1016\/j.suc.2018.12.008_bib27","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.21873\/anticanres.11602","article-title":"Primary non-hodgkin's lymphoma of the gallbladder: a population-based analysis","volume":"37","author":"Ayub","year":"2017","journal-title":"Anticancer Res"},{"issue":"4","key":"10.1016\/j.suc.2018.12.008_bib28","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1245\/s10434-008-0189-3","article-title":"Analysis of the extent of resection for adenocarcinoma of the gallbladder","volume":"16","author":"D'Angelica","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.suc.2018.12.008_bib29","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.amjsurg.2017.02.006","article-title":"Predictors of curative resection and long term survival of gallbladder cancer - A retrospective analysis","volume":"214","author":"Mishra","year":"2017","journal-title":"Am J Surg"},{"issue":"8","key":"10.1016\/j.suc.2018.12.008_bib30","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s11605-017-3440-z","article-title":"Gallbladder cancer presenting with jaundice: uniformly fatal or still potentially curable?","volume":"21","author":"Tran","year":"2017","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.suc.2018.12.008_bib31","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1016\/j.crad.2015.10.016","article-title":"Gallbladder carcinoma: causes of misdiagnosis at CT","volume":"71","author":"Kim","year":"2016","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.suc.2018.12.008_bib32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.clinimag.2012.05.009","article-title":"Computed tomography for assessing resectability of gallbladder carcinoma: a systematic review and meta-analysis","volume":"37","author":"Li","year":"2013","journal-title":"Clin Imaging"},{"issue":"40","key":"10.1016\/j.suc.2018.12.008_bib33","doi-asserted-by":"crossref","first-page":"11481","DOI":"10.3748\/wjg.v21.i40.11481","article-title":"Diagnostic accuracy of fluorine-18-fluorodeoxyglucose positron emission tomography in gallbladder cancer: a meta-analysis","volume":"21","author":"Annunziata","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.suc.2018.12.008_bib34","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/jso.20533","article-title":"Application of modern imaging methods in diagnosis of gallbladder cancer","volume":"93","author":"Rodriguez-Fernandez","year":"2006","journal-title":"J\u00a0Surg Oncol"},{"issue":"1","key":"10.1016\/j.suc.2018.12.008_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jamcollsurg.2007.07.002","article-title":"18F-fluorodeoxyglucose positron emission tomography influences management decisions in patients with biliary cancer","volume":"206","author":"Corvera","year":"2008","journal-title":"J\u00a0Am Coll Surg"},{"issue":"7","key":"10.1016\/j.suc.2018.12.008_bib36","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1477-2574.2009.00104.x","article-title":"The role of PET-CT in patients with incidental gallbladder cancer","volume":"11","author":"Butte","year":"2009","journal-title":"HPB (Oxford)"},{"issue":"3","key":"10.1016\/j.suc.2018.12.008_bib37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1477-2574.2012.00539.x","article-title":"A\u00a0prospective analysis of the preoperative assessment of duodenal involvement in gallbladder cancer","volume":"15","author":"Kalayarasan","year":"2013","journal-title":"HPB (Oxford)"},{"issue":"7","key":"10.1016\/j.suc.2018.12.008_bib38","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s11605-013-2209-2","article-title":"Mass-forming xanthogranulomatous cholecystitis masquerading as gallbladder cancer","volume":"17","author":"Agarwal","year":"2013","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.suc.2018.12.008_bib39","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/SLA.0b013e318271497e","article-title":"The role of staging laparoscopy in primary gall bladder cancer--an analysis of 409 patients: a prospective study to evaluate the role of staging laparoscopy in the management of gallbladder cancer","volume":"258","author":"Agarwal","year":"2013","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.suc.2018.12.008_bib40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/jmas.JMAS_223_16","article-title":"Laparoscopic versus open treatment of gallbladder cancer: A systematic review and meta-analysis","volume":"14","author":"Zhao","year":"2018","journal-title":"J\u00a0Minim Access Surg"},{"issue":"2","key":"10.1016\/j.suc.2018.12.008_bib41","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/jamasurg.2016.3642","article-title":"Association of optimal time interval to re-resection for incidental gallbladder cancer with overall survival: a multi-institution analysis from the US extrahepatic biliary malignancy consortium","volume":"152","author":"Ethun","year":"2017","journal-title":"JAMA Surg"},{"issue":"7","key":"10.1016\/j.suc.2018.12.008_bib42","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jso.21141","article-title":"Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC)","volume":"98","author":"Duffy","year":"2008","journal-title":"J\u00a0Surg Oncol"},{"issue":"6","key":"10.1016\/j.suc.2018.12.008_bib43","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/SLA.0b013e31806beec2","article-title":"Gallbladder cancer: the role of laparoscopy and radical resection","volume":"245","author":"Shih","year":"2007","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.suc.2018.12.008_bib44","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1245\/s10434-009-0538-x","article-title":"Evolving treatment strategies for gallbladder cancer","volume":"16","author":"Hueman","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.suc.2018.12.008_bib45","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s11605-008-0772-8","article-title":"A\u00a0critical analysis of the surgical management of early-stage gallbladder cancer in the United States","volume":"13","author":"Jensen","year":"2009","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"3","key":"10.1016\/j.suc.2018.12.008_bib46","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jamcollsurg.2014.01.069","article-title":"Residual disease predicts outcomes after definitive resection for incidental gallbladder cancer","volume":"219","author":"Butte","year":"2014","journal-title":"J\u00a0Am Coll Surg"},{"issue":"1","key":"10.1016\/j.suc.2018.12.008_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11605-017-3507-x","article-title":"Extended lymphadenectomy is required for incidental gallbladder cancer independent of cystic duct lymph node status","volume":"22","author":"Vega","year":"2018","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"7","key":"10.1016\/j.suc.2018.12.008_bib48","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1477-2574.2011.00325.x","article-title":"The role of laparoscopic staging in patients with incidental gallbladder cancer","volume":"13","author":"Butte","year":"2011","journal-title":"HPB (Oxford)"},{"issue":"Suppl 2","key":"10.1016\/j.suc.2018.12.008_bib49","article-title":"Managing the incidentally detected gallbladder cancer: algorithms and controversies","volume":"12","author":"Cavallaro","year":"2014","journal-title":"Int J Surg"},{"issue":"2","key":"10.1016\/j.suc.2018.12.008_bib50","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00534-009-0044-3","article-title":"Hepatic resection in 485 R0 pT2 and pT3 cases of advanced carcinoma of the gallbladder: results of a Japanese Society of Biliary Surgery survey\u2013a multicenter study","volume":"16","author":"Araida","year":"2009","journal-title":"J\u00a0Hepatobiliary Pancreat Surg"},{"issue":"6","key":"10.1016\/j.suc.2018.12.008_bib51","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jso.21681","article-title":"Incidental gallbladder cancer: analysis of surgical findings and survival","volume":"102","author":"Butte","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"issue":"5","key":"10.1016\/j.suc.2018.12.008_bib52","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/SLA.0b013e318216f5f3","article-title":"Gallbladder cancer involving the extrahepatic bile duct is worthy of resection","volume":"253","author":"Nishio","year":"2011","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.suc.2018.12.008_bib53","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.surg.2009.06.056","article-title":"Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer","volume":"146","author":"Jensen","year":"2009","journal-title":"Surgery"},{"issue":"22","key":"10.1016\/j.suc.2018.12.008_bib54","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.3748\/wjg.v18.i22.2775","article-title":"Regional lymphadenectomy for gallbladder cancer: rational extent, technical details, and patient outcomes","volume":"18","author":"Shirai","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.suc.2018.12.008_bib55","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s11605-011-1528-4","article-title":"Lymph nodal involvement as prognostic factor in gallbladder cancer: location, count or ratio?","volume":"15","author":"Negi","year":"2011","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"2","key":"10.1016\/j.suc.2018.12.008_bib56","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/SLA.0b013e31822238d8","article-title":"Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment","volume":"254","author":"Ito","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.suc.2018.12.008_bib57","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jss.2018.04.067","article-title":"Validation of American Joint Committee on Cancer eighth staging system for gallbladder cancer and its lymphadenectomy guidelines","volume":"230","author":"Lee","year":"2018","journal-title":"J\u00a0Surg Res"},{"issue":"3","key":"10.1016\/j.suc.2018.12.008_bib58","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.surg.2016.08.007","article-title":"Trends in port-site metastasis after laparoscopic resection of incidental gallbladder cancer: a systematic review","volume":"161","author":"Berger-Richardson","year":"2017","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.suc.2018.12.008_bib59","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S1055-3207(02)00041-8","article-title":"Surgical indications and extent of resection in gallbladder cancer","volume":"11","author":"Shoup","year":"2002","journal-title":"Surg Oncol Clin N Am"},{"issue":"2","key":"10.1016\/j.suc.2018.12.008_bib60","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1245\/s10434-011-1850-9","article-title":"Is port site resection necessary in the surgical management of gallbladder cancer?","volume":"19","author":"Maker","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.suc.2018.12.008_bib61","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s11605-007-0309-6","article-title":"Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection","volume":"11","author":"Pawlik","year":"2007","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"8","key":"10.1016\/j.suc.2018.12.008_bib62","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1245\/s10434-017-5859-6","article-title":"Incidental gallbladder cancer: residual cancer discovered at oncologic extended resection determines outcome: a report from high- and low-incidence countries","volume":"24","author":"Vinuela","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.suc.2018.12.008_bib63","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/j.1477-2574.2009.00108.x","article-title":"Radical resection for T1b gallbladder cancer: a decision analysis","volume":"11","author":"Abramson","year":"2009","journal-title":"HPB (Oxford)"},{"issue":"1","key":"10.1016\/j.suc.2018.12.008_bib64","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1477-2574.2012.00559.x","article-title":"A\u00a021-year analysis of stage I gallbladder carcinoma: is cholecystectomy alone adequate?","volume":"15","author":"Hari","year":"2013","journal-title":"HPB (Oxford)"},{"issue":"3","key":"10.1016\/j.suc.2018.12.008_bib65","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.sla.0000154118.07704.ef","article-title":"An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center","volume":"241","author":"Dixon","year":"2005","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.suc.2018.12.008_bib66","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/SLA.0000000000000728","article-title":"Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study","volume":"261","author":"Shindoh","year":"2015","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.suc.2018.12.008_bib67","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.surg.2017.05.004","article-title":"Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study","volume":"162","author":"Lee","year":"2017","journal-title":"Surgery"},{"issue":"8","key":"10.1016\/j.suc.2018.12.008_bib68","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/hpb.12032","article-title":"Incidental pT2-T3 gallbladder cancer after a cholecystectomy: outcome of staging at 3\u00a0months prior to a radical resection","volume":"15","author":"Ausania","year":"2013","journal-title":"HPB (Oxford)"},{"issue":"6","key":"10.1016\/j.suc.2018.12.008_bib69","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/hpb.12406","article-title":"Minimally invasive versus the conventional open surgical approach of a radical cholecystectomy for gallbladder cancer: a retrospective comparative study","volume":"17","author":"Agarwal","year":"2015","journal-title":"HPB (Oxford)"},{"issue":"12","key":"10.1016\/j.suc.2018.12.008_bib70","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1007\/s00464-015-4116-y","article-title":"Novel strategy for laparoscopic treatment of pT2 gallbladder carcinoma","volume":"29","author":"Itano","year":"2015","journal-title":"Surg Endosc"},{"issue":"8","key":"10.1016\/j.suc.2018.12.008_bib71","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/jso.25086","article-title":"Association of perioperative transfusion with survival and recurrence after resection of gallbladder cancer: A 10-institution study from the US Extrahepatic Biliary Malignancy Consortium","volume":"117","author":"Lopez-Aguiar","year":"2018","journal-title":"J\u00a0Surg Oncol"},{"issue":"7","key":"10.1016\/j.suc.2018.12.008_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djw324","article-title":"Limited use of adjuvant therapy in patients with resected gallbladder cancer despite a strong association with survival","volume":"109","author":"Mitin","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.suc.2018.12.008_bib73","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jamcollsurg.2016.12.058","article-title":"Systemic chemotherapy combined with resection for locally advanced gallbladder carcinoma: surgical and survival outcomes","volume":"224","author":"Creasy","year":"2017","journal-title":"J\u00a0Am Coll Surg"},{"issue":"16","key":"10.1016\/j.suc.2018.12.008_bib74","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","article-title":"Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis","volume":"30","author":"Horgan","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suc.2018.12.008_bib75","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1186\/s12885-015-1617-y","article-title":"Adjuvant therapy in the treatment of gallbladder cancer: a meta-analysis","volume":"15","author":"Ma","year":"2015","journal-title":"BMC Cancer"},{"issue":"35","key":"10.1016\/j.suc.2018.12.008_bib76","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1200\/JCO.2010.33.8020","article-title":"Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer","volume":"29","author":"Wang","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.suc.2018.12.008_bib77","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw202","article-title":"Adjuvant therapy for resected gallbladder cancer: analysis of the national cancer data base","volume":"109","author":"Mantripragada","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.suc.2018.12.008_bib78","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijsu.2018.02.052","article-title":"Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study)","volume":"52","author":"Bergquist","year":"2018","journal-title":"Int J Surg"},{"issue":"9","key":"10.1016\/j.suc.2018.12.008_bib79","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.hpb.2017.05.010","article-title":"Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis","volume":"19","author":"Ghidini","year":"2017","journal-title":"HPB (Oxford)"},{"issue":"10","key":"10.1016\/j.suc.2018.12.008_bib80","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1007\/s11605-015-2922-0","article-title":"Adjuvant therapy for gallbladder cancer: an analysis of the national cancer data base","volume":"19","author":"Hoehn","year":"2015","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.suc.2018.12.008_bib81","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijrobp.2017.09.029","article-title":"Concurrent chemoradiotherapy in curatively resected gallbladder carcinoma: a propensity score-matched analysis","volume":"100","author":"Gu","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.suc.2018.12.008_bib82","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3857\/roj.2017.00388","article-title":"Patterns of initial failure after resection for gallbladder cancer: implications for adjuvant radiotherapy","volume":"35","author":"Kim","year":"2017","journal-title":"Radiat Oncol J"},{"issue":"1","key":"10.1016\/j.suc.2018.12.008_bib83","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/cncr.30968","article-title":"The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts","volume":"124","author":"Tran Cao","year":"2018","journal-title":"Cancer Cytopathol"},{"issue":"14","key":"10.1016\/j.suc.2018.12.008_bib84","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.suc.2018.12.008_bib85","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00280-017-3353-2","article-title":"Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients","volume":"80","author":"Kim","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"10.1016\/j.suc.2018.12.008_bib86","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s13193-015-0443-7","article-title":"Chemotherapy compared with best supportive care for metastatic\/unresectable gallbladder cancer: a non-randomized prospective cohort study","volume":"7","author":"Singh","year":"2016","journal-title":"Indian J Surg Oncol"},{"issue":"1","key":"10.1016\/j.suc.2018.12.008_bib87","doi-asserted-by":"crossref","first-page":"59","DOI":"10.6004\/jnccn.2017.7067","article-title":"Chemoradiotherapy versus chemotherapy alone for unresected nonmetastatic gallbladder cancer: National practice patterns and outcomes","volume":"16","author":"Verma","year":"2018","journal-title":"J\u00a0Natl Compr Cancer Netw"},{"issue":"4","key":"10.1016\/j.suc.2018.12.008_bib88","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S1055-3207(02)00038-8","article-title":"Palliative and postoperative radiotherapy in biliary tract cancer","volume":"11","author":"Macdonald","year":"2002","journal-title":"Surg Oncol Clin N Am"},{"issue":"5","key":"10.1016\/j.suc.2018.12.008_bib89","doi-asserted-by":"crossref","first-page":"797","DOI":"10.21037\/jgo.2016.09.01","article-title":"Molecular profiling of biliary tract cancer: a target rich disease","volume":"7","author":"Jain","year":"2016","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"10.1016\/j.suc.2018.12.008_bib90","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s10555-016-9602-8","article-title":"Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design","volume":"35","author":"Sicklick","year":"2016","journal-title":"Cancer Metastasis Rev"},{"issue":"19","key":"10.1016\/j.suc.2018.12.008_bib91","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1200\/JCO.2005.05.3579","article-title":"Phase II study of erlotinib in patients with advanced biliary cancer","volume":"24","author":"Philip","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"21","key":"10.1016\/j.suc.2018.12.008_bib92","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1200\/JCO.2010.28.4075","article-title":"Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study","volume":"28","author":"Lubner","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"issue":"4","key":"10.1016\/j.suc.2018.12.008_bib93","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/bjc.2013.801","article-title":"S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma","volume":"110","author":"El-Khoueiry","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.suc.2018.12.008_bib94","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s12885-015-1552-y","article-title":"Tumour shrinkage at 6\u00a0weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer","volume":"15","author":"Kim","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.suc.2018.12.008_bib95","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-015-0155-z","article-title":"HER2\/neu-directed therapy for biliary tract cancer","volume":"8","author":"Javle","year":"2015","journal-title":"J\u00a0Hematol Oncol"},{"issue":"12","key":"10.1016\/j.suc.2018.12.008_bib96","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S1470-2045(10)70247-3","article-title":"Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study","volume":"11","author":"Gruenberger","year":"2010","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.suc.2018.12.008_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00534-008-0015-0","article-title":"Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan","volume":"16","author":"Miyakawa","year":"2009","journal-title":"J\u00a0Hepatobiliary Pancreat Surg"}],"container-title":["Surgical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610918301786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039610918301786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,29]],"date-time":"2020-11-29T05:14:08Z","timestamp":1606626848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039610918301786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":97,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0039610918301786"],"URL":"https:\/\/doi.org\/10.1016\/j.suc.2018.12.008","relation":{},"ISSN":["0039-6109"],"issn-type":[{"value":"0039-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gallbladder Cancer","name":"articletitle","label":"Article Title"},{"value":"Surgical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suc.2018.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}